MING LIN , PHd

aNTARES therapeutics

Ming Lin is the Vice President of Biometrics at Antares Therapeutics (formerly Scorpion Therapeutics). Prior to Antares, Ming held various leadership positions at several biotech companies, including head of biometrics at Nkarta Therapeutics, head of biostatistics at Forty Seven Inc., and head of oncology biostatistics at Gilead Sciences. Prior to these roles, Ming spent 6 years at Genentech, where he supported all phases of oncology clinical trials.

Ming received his Ph.D. in Biostatistics from Harvard. His undergraduate studies were at the University of Science and Technology of China, where he received a B.S. in Computer Science.